Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract infection: a case series

Recurrent urinary tract infections are recalcitrant and difficult-to-treat bacterial infections that primarily affect women. Here we combine phage therapy with faecal microbiota transplantation to decolonize the urinary and intestinal reservoirs of patients with recurrent urinary tract infections. Three women received oral and intravesical phage therapy for 8 days, and two underwent subsequent faecal microbiota transplantation. Treatments were well tolerated, and although Escherichia coli was detected in follow-up samples, patients experienced none or fewer and less severe episodes of urinary tract infection 24 months post-treatment.

Authors

Institutions

Publication Details

Journal
Nature Microbiology
Published
2026-07-30
DOI
https://doi.org/10.1038/s41564-026-02409-0
Primary Topic
Bacteriophages and microbial interactions
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract infection: a case series

Jiemin Du, Fedja Farowski, Sonja Milek, Lorenz Leitner et al.
Nature Microbiology
Bacteriophages and microbial interactions
article

Combined phage therapy and faecal microbiota transplantation to treat recurrent urinary tract infection: a case series

Jiemin Du, Fedja Farowski, Sonja Milek, Lorenz Leitner, Shawna E. McCallin, Swenja Lassen, Martin J. Loessner, Annika Y. Claßen, Hendrik Koliwer‐Brandl, André Kahles, Oksana Mykolaivna Chemych, Paul G. Higgins, Matthew Dunne, Jens Scheidegger, Jonas Eigler, Fatih Abdula, Lena M. Biehl, Thomas M. Kessler, Oliver Gross, Sarah Dugas, Simone C. Lieberknecht-Jouy, Maria J. G. T. Vehreschild
article en

Abstract

Recurrent urinary tract infections are recalcitrant and difficult-to-treat bacterial infections that primarily affect women. Here we combine phage therapy with faecal microbiota transplantation to decolonize the urinary and intestinal reservoirs of patients with recurrent urinary tract infections. Three women received oral and intravesical phage therapy for 8 days, and two underwent subsequent faecal microbiota transplantation. Treatments were well tolerated, and although Escherichia coli was detected in follow-up samples, patients experienced none or fewer and less severe episodes of urinary tract infection 24 months post-treatment.

Nature MicrobiologyVol. 11(8)
Goethe University Frankfurt (DE), SIB Swiss Institute of Bioinformatics (CH), University of Cologne (DE), University of Zurich (CH), Sumy State University (UA), ETH Zurich (CH), University Hospital of Zurich (CH), Fraunhofer Institute for Translational Medicine and Pharmacology (DE), German Center for Infection Research (DE), Center for Pediatric Endocrinology Zurich (CH), Universitätsklinik Balgrist (CH), University Hospital Frankfurt (DE), European Society of Clinical Microbiology and Infectious Diseases (CH), University Hospital Cologne (DE)
National Science Foundation, Deutsches Zentrum für Infektionsforschung, European Commission, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Universität Zürich, H2020 Marie Skłodowska-Curie Actions
Good health and well-being
Openalex Percentile: Top 9%
Bacteriophages and microbial interactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.